GORE® Endo Anchor® System
GPTKB entity
Statements (49)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:hospital
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:Gore_Interventional_Devices
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:benefits |
improved patient outcomes
shorter recovery time reduced risk of migration |
gptkbp:clinical_trial |
ongoing
abdominal aortic aneurysms supporting studies available thoracic aortic aneurysms |
gptkbp:collaborations |
with medical institutions
|
gptkbp:education |
important for understanding procedure
|
gptkbp:events |
necessary after procedure
|
gptkbp:features |
anchor technology
|
gptkbp:feedback |
generally positive
|
gptkbp:first_introduced |
gptkb:2015
|
https://www.w3.org/2000/01/rdf-schema#label |
GORE® Endo Anchor® System
|
gptkbp:invasive_potential |
gptkb:theorem
|
gptkbp:is_compatible_with |
various endovascular grafts
|
gptkbp:is_designed_for |
aortic aneurysms
|
gptkbp:is_monitored_by |
required post-implantation
|
gptkbp:is_used_for |
endovascular repair
|
gptkbp:manufacturer |
gptkb:W._L._Gore_&_Associates
|
gptkbp:market |
global
|
gptkbp:part_of |
endovascular aortic repair solutions
|
gptkbp:population_trend |
growing demand for minimally invasive solutions
|
gptkbp:project |
expected in technology
|
gptkbp:provides |
stability to endovascular grafts
|
gptkbp:provides_information_on |
available for use
|
gptkbp:regulatory_compliance |
CE Marked
FDA approved |
gptkbp:research_focus |
long-term outcomes
enhancing patient safety improving device design |
gptkbp:risk_factor |
thromboembolic events
infection risk potential complications bleeding complications device migration |
gptkbp:shipping_options |
catheter-based delivery
|
gptkbp:side_effect |
significant in vascular surgery.
|
gptkbp:specialties |
endovascular surgery
|
gptkbp:target_audience |
elderly patients
patients with aortic disease |
gptkbp:training |
for healthcare professionals
available for surgeons |
gptkbp:treatment |
monitored in studies
evaluated in clinical trials |